Explainable Multi-Omics Transformer Risk Stratification in Lung Adenocarcinoma: External Validation, Calibration, and Patient-Level Genomic Attribution
- Lung adenocarcinoma (LUAD) remains biologically heterogeneous and clinically difficult to stratify with a single data modality. Transformer architectures can, in principle, model cross-modality interactions among RNA expression, somatic mutation, copy-number variation (CNV), and clinical variables, but their clinical...